Latest Stock Market News

The S&P BSE Sensex rallied nearly 500 points while the Nifty50 closed above 19100 levels. Sectorally, buying was seen in realty, telecom, metal, and public sector stocks.

Revenue from operations increased 7% year-on-year to Rs 3,204 crore in the reporting period. The Board has also approved an interim dividend of Rs 2.75 per equity share for the financial year 2023-24.

Under the OFS, promoter selling shareholder ESAF Financial Holdings will offload a stake worth Rs 49 crore and other selling shareholders PNB MetLife and Bajaj Allianz Life make up for the remaining OFS portion.

Despite publishing forecasts which now show the British economy now skirting close to a recession and flat-lining in the coming years, the BoE held Bank Rate at 5.25% for the second meeting in a row after 14 back-to-back increases. It also reinforced its message that borrowing costs were set to stay high, even though only about half of the impact of its long run of rate hikes have been felt in the economy so far.

“I expect the demand story around the consumer goods basket to remain fairly healthy right up to the parliamentary election. That augurs well. Though the numbers have not been great, I would still say that it is a good point to accumulate consumer stocks at this point in time, given the outlook for the next six months.”

Macro events, Fed, BoE, macro events in November, China Consumer Price Index, India IIP data

"If you are hospitalised for say five days and if I take a cover which is Rs 500, then you get Rs 500 for five days – Rs 2,500 total. These coverages can be taken from 500 to 25,000 per day, so this is that vast. If I were to think that my other miscellaneous expenses are going to be more than 2,000, 3,000 per day, then I would take a hospital cash policy which would cover me for that because that again is an expense that pinches your pocket."

TCHF II has already allocated 60% of the $130 million corpus raised last year. It has concluded seven investments to date. The current TCHF II portfolio is strategically diversified across domestic and export pharmaceuticals, cancer care clinics, dialysis centers, integrated regional diagnostic chains, and digital healthcare.